Supernus Pharmaceuticals
SUPN
#5129
Rank
S$2.23 B
Marketcap
S$38.32
Share price
1.78%
Change (1 day)
-34.77%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -S$47.18 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are S$0.86 Billion. In 2025 the company made an earning of -S$54.45 Million a decrease over its 2024 earnings that were of S$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$47.18 Million-13.35%
2025 -S$54.45 Million-152.66%
2024 S$0.10 B1446.62%
2023 S$6.68 M-92.36%
2022 S$87.43 M-29.8%
2021 S$0.12 B-49.79%
2020 S$0.24 B12.99%
2019 S$0.21 B7.58%
2018 S$0.20 B54.9%
2017 S$0.13 B84.25%
2016 S$71.5 M202.27%
2015 S$23.65 M-462.04%
2014 -S$6.54 Million-94%
2013 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.13 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$9.30 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.83 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-S$0.28 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$1.95 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA